UTHR
NASDAQStockUnited Therapeutics Corporation
$535.60-9.14 (-1.68%)
52-Week Range
$274.70
$535.81
Key Stats
Market Cap
23.5B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.86
Volume
377.4K
Avg Volume
574.1K
Performance
1M
+13.23%
3M
+8.47%
6M
+32.92%
YTD
+7.87%
1Y
+74.48%
3Y
+142.82%
5Y
+226.51%
Price Chart
ETF Exposure
UTHR is held by 241 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| PINK | Simplify Health Care ETF | 6.29% |
| PBE | Invesco Biotechnology & Genome ETF | 5.94% |
| HELX | Franklin Genomic Advancements ETF | 4.15% |
| GLRY | Inspire Growth ETF | 3.97% |
| FBT | First Trust NYSE Arca Biotechnology Index Fund | 3.96% |
| XMHQ | Invesco S&P MidCap Quality ETF | 3.84% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 3.52% |
| PJP | Invesco Pharmaceuticals ETF | 3.29% |
| BBH | VanEck Biotech ETF | 3.21% |
| PTH | Invesco Dorsey Wright Healthcare Momentum ETF | 2.89% |
| ASCE | Allspring SMID Core ETF | 2.57% |
| BUL | Pacer US Cash Cows Growth ETF | 2.52% |
| WDNA | WisdomTree BioRevolution Fund | 2.43% |
| FGSI | FT Vest Growth Strength & Target Income ETF | 2.35% |
| FTGS | First Trust Growth Strength ETF | 2.35% |
| XOVR | ERShares Private-Public Crossover ETF | 2.12% |
| KONG | Formidable Fortress ETF | 2.04% |
| FXH | First Trust Health Care AlphaDEX Fund | 2.02% |
| IBB | iShares Biotechnology ETF | 1.94% |
| COWG | Pacer US Large Cap Cash Cows Growth Leaders ETF | 1.87% |
| EWMC | Invesco S&P MidCap 400 Equal Weight ETF | 1.75% |
| GRPM | Invesco S&P MidCap 400 GARP ETF | 1.75% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 1.75% |
| IQSM | NYLI Candriam U.S. Mid Cap Equity ETF | 1.68% |
| BBP | Virtus Biotech ETF | 1.66% |
| QQQN | VictoryShares Nasdaq Next 50 ETF | 1.57% |
| RFG | Invesco S&P MidCap 400 Pure Growth ETF | 1.55% |
| FCPI | FIDELITY STOCKS FOR INFLATION ETF | 1.42% |
| AGNG | Global X - Aging Population ETF | 1.40% |
| XBI | State Street SPDR S&P Biotech ETF | 1.35% |
| VFLO | VictoryShares Free Cash Flow ETF | 1.34% |
| IJK | iShares S&P Mid-Cap 400 Growth ETF | 1.33% |
| MDYG | State Street SPDR S&P 400 Mid Cap Growth ETF | 1.33% |
| GURU | Global X - Guru Index ETF | 1.31% |
| SMOX | Horizon Small/Mid Cap Core Equity ETF | 1.27% |
| DVLU | First Trust Dorsey Wright Momentum & Value ETF | 1.21% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 1.19% |
| IVOG | Vanguard S&P Mid-Cap 400 Growth ETF | 1.17% |
| QQQJ | Invesco NASDAQ Next Gen 100 ETF | 1.17% |
| RNMC | First Trust Mid Cap US Equity Select ETF | 1.13% |
| MIDE | Xtrackers S&P MidCap 400 Scored & Screened ETF | 1.09% |
| QQJG | Invesco ESG NASDAQ Next Gen 100 ETF | 1.08% |
| LSAF | LeaderSharesTM AlphaFactor US Core Equity ETF | 1.06% |
| FDLS | Inspire Fidelis Multi Factor ETF | 1.03% |
| JDOC | JPMorgan Healthcare Leaders ETF | 0.96% |
| FLQM | Franklin U.S. Mid Cap Multifactor Index ETF | 0.95% |
| BSMC | Brandes U.S. Small-Mid Cap Value ETF | 0.90% |
| LNGR | Global X Aging Population ETF | 0.87% |
| AFMC | First Trust Active Factor Mid Cap ETF | 0.87% |
| VLLU | Harbor AlphaEdge Large Cap Value ETF (VLLU) | 0.84% |
Page 1 of 5Next
About UTHR ETF Exposure
United Therapeutics Corporation (UTHR) is held by 241 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 23.5B, UTHR is a widely held institutional stock. The stock currently trades at $535.60. Investors can gain exposure to UTHR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold UTHR, sorted by portfolio weight.